Multiple sclerosis – www.brainwork.md

30th April 2021

Vaccines and MS – are they still effective?

https://www.brainwork.md/content/uploads/2021/04/Brainwork-Vaccines-and-MS-–-are-they-still-effective.jpg 1000 662 Bradley Schussel Bradley Schussel https://secure.gravatar.com/avatar/6b6a050be6255edf61b200407949f10c?s=96&d=mm&r=g 30th April 2021 30th April 2021

During the coronavirus disease 2019 (COVID-19) pandemic, vaccines have been at the forefront of the public consciousness. This is especially true for individuals with multiple sclerosis (MS), as some may…

Bradley Schussel
0
0

2nd February 2021

No negative effects of COVID-19 lockdown on migraine patients treated with CGRP inhibitors

https://www.brainwork.md/content/uploads/2020/11/Brainwork-No-negative-effects-of-COVID-19-lockdown-on-migraine-patients-treated-with-CGRP-inhibitors-scaled.jpg 2560 1440 Anna Stelling, PhD Anna Stelling, PhD https://secure.gravatar.com/avatar/03d32c6dd44674dd6ad1a82129cbc197?s=96&d=mm&r=g 2nd February 2021 2nd February 2021

It has been shown that everyday habits, lifestyle and stress can have a substantial influence on migraine frequency.1,2 The COVID-19 pandemic significantly disrupted the everyday life of people around the…

Anna Stelling, PhD
0
0

18th September 2020

Ageing in multiple sclerosis – what do we know?

https://www.brainwork.md/content/uploads/2020/09/Brainwork-Ageing-in-multiple-sclerosis-–-what-do-we-know.png 2846 1601 Anna Stelling, PhD Anna Stelling, PhD https://secure.gravatar.com/avatar/03d32c6dd44674dd6ad1a82129cbc197?s=96&d=mm&r=g 18th September 2020 23rd September 2020

“Ageing comes with many issues in multiple sclerosis (MS): progression, comorbidities, cognition problems and response to treatment”, Pierre Duquette (Department of Neuroscience, University of Montreal, Canada), the chair of the…

Anna Stelling, PhD
0
0

18th September 2020

How to promote remyelination in MS

https://www.brainwork.md/content/uploads/2020/09/Brainwork-How-to-promote-remyelination-in-MS.png 2846 1601 Anne Carter, MA (Cantab) Anne Carter, MA (Cantab) https://secure.gravatar.com/avatar/8a0679fc29066255ffcb2a69eacf9ee3?s=96&d=mm&r=g 18th September 2020 18th September 2020

Strategies to promote remyelination was a hot topic at this year’s virtual ACTRIMS/ECTRIMS joint meeting, with three expert presenters each addressing a different aspect of the subject, including the role…

Anne Carter, MA (Cantab)
0
0

17th September 2020

Does the microbiome have a role in MS?

https://www.brainwork.md/content/uploads/2020/09/MPR761-KSA-Content-Development-Brainwork-ECTRIMS-20200918_bacteria-article-2.png 2846 1600 Anne Carter, MA (Cantab) Anne Carter, MA (Cantab) https://secure.gravatar.com/avatar/8a0679fc29066255ffcb2a69eacf9ee3?s=96&d=mm&r=g 17th September 2020 18th September 2020

Can the bacteria living in your gut influence multiple sclerosis (MS) susceptibility and risk of relapse? That was the question Emmanuelle Waubant (University of California, San Francisco, USA) posed during…

Anne Carter, MA (Cantab)
0
0

17th September 2020

Is disease-modifying treatment in primary progressive multiple sclerosis effective after all?

https://www.brainwork.md/content/uploads/2020/09/Brainwork-ECTRIMS-Is-disease-modifying-treatment-primary-progressive-multiplesclerosis-effective-after-all-scaled.jpg 1703 2560 Anna Stelling, PhD Anna Stelling, PhD https://secure.gravatar.com/avatar/03d32c6dd44674dd6ad1a82129cbc197?s=96&d=mm&r=g 17th September 2020 18th September 2020

Until now, several randomised controlled trials and real-world studies could not show the clinical benefit of disease‑modifying treatments (DMTs) in primary progressive multiple sclerosis (PPMS).1-4 However, some recently published results…

Anna Stelling, PhD
0
0

17th September 2020

Neurofilament light chain levels as a biomarker in multiple sclerosis

https://www.brainwork.md/content/uploads/2020/09/Brainwork-ECTRIMS-Neurofilament-light-chain-levels-as-a-biomarker-in-multiple-sclerosis-scaled.jpg 1703 2560 Anna Stelling, PhD Anna Stelling, PhD https://secure.gravatar.com/avatar/03d32c6dd44674dd6ad1a82129cbc197?s=96&d=mm&r=g 17th September 2020 18th September 2020

It has been previously shown that the neuronal cytoskeletal protein neurofilament light chain (NfL) is released into the blood and cerebrospinal fluid (CSF) upon neuroaxonal injury.1 Hence it was not…

Anna Stelling, PhD
0
0

17th September 2020

Do hormonal changes influence MS in women?

https://www.brainwork.md/content/uploads/2020/09/Brainwork-Do-hormonal-changes-influence-MS-in-women.jpg 2400 1600 Anne Carter, MA (Cantab) Anne Carter, MA (Cantab) https://secure.gravatar.com/avatar/8a0679fc29066255ffcb2a69eacf9ee3?s=96&d=mm&r=g 17th September 2020 23rd September 2020

There is a paradox in multiple sclerosis (MS): females appear to be more susceptible to the disease than males, but also have a better long-term prognosis. Could this be due…

Anne Carter, MA (Cantab)
0
0

29th May 2020

Siponimod shows promising long-term efficacy in SPMS patients

https://www.brainwork.md/content/uploads/2020/05/Brainwork-LongTermEfficacy-e1590771801837.jpg 1920 1280 Anna Stelling, PhD Anna Stelling, PhD https://secure.gravatar.com/avatar/03d32c6dd44674dd6ad1a82129cbc197?s=96&d=mm&r=g 29th May 2020 2nd June 2020

While researchers are looking at the potential of stem cells in the treatment of multiple sclerosis (MS), novel, promising immune-modulating therapies are being developed. At this year’s virtual EAN Congress,…

Anna Stelling, PhD
0
0

29th May 2020

Paediatric multiple sclerosis: Adding to our knowledge

https://www.brainwork.md/content/uploads/2020/05/MPR761-KSA-Brainwork-2020-EAN-GC-V00-03-20200528_probability-marbles-e1590771823562.jpg 1920 1080 Anne Carter, MA (Cantab) Anne Carter, MA (Cantab) https://secure.gravatar.com/avatar/8a0679fc29066255ffcb2a69eacf9ee3?s=96&d=mm&r=g 29th May 2020 29th May 2020

Data suggest that between 2 and 5% of patients with multiple sclerosis (MS) are under 18 years old,1 yet there is only one approved treatment option in this population.2,3 During…

Anne Carter, MA (Cantab)
0
0